Tags : Summer 2020

COVID-19 Pharma

CoVIg-19 Plasma Alliance to Initiate Clinical Study Evaluating Hyperimmune Therapy

Shots: Shots: Takeda, CSL and NIH’s, CoVIg-19 Plasma Alliance has expanded membership and CT collaborations with >10 plasma and non-plasma companies globally to develop a plasma-derived hyperimmune globulin therapy against COVID-19 The news member to the program includes ADMA Biologics, BioPharma Plasma, GC Pharma, and Sanquin. All the organization will provide specialist advisory expertise, technical […]Read More